Motor neuron disease 1 Flashcards
- clinical characteristics - genetics (familial v sporadic) - pathological features
neurodegenerative disease
disease that selectively kills neurons and progresses over time
ALS - full name
amyotrophic lateral sclerosis
sometimes referred to as Lou gehrigs
ALS - how does it work
- motor neurons degenration
- reduced signals to musces
- NMJ disrupted
- muscle wasting and weakness
- progressive paralysis
ALS after onset
- fatal within 2-5 years of symptomatic onset
- limited treatment options / no cure
clinical symptoms of ALS in the limbs/spine (corticospino tract)
- muscle stiffness /spasticity and cramps
- muscle twitching
- weakness in arms, legs, hands, feet
- poor grip strentch
(spreading of muscle weakness inward)
clinical symptoms of ALS in bulbar (corticobasal tract)
- degeneration of corticobulbar tract
- weakness
- difficulty swallowing
- pooling of saliva
- spasm of vocal cords
- slow or slurred speech
(spreading of muscle weakness outward)
cognitive symptoms of ALS
- episodic memory impairments
- atrophy of frontal and temporal lobes
- personality changes/ language disorder
what kind of dementia do ALS patients tend to be diagnoses with and whats the rate
- 15% develop frontotemporal dementia (FTD)
genetics of ALS
- 5-10% ALS hereditary - FALS (remainder is sporadic - SALS)
- heterogeneous disease
- some mutations cause both ALS and FTD
ALS key mutations
- SOD1
- C9orf72
- TARDBP
SOD1 mutations in ALS
- first mutation discovered
- 10-20% familial cases, 1-2% sporadic
- copper-zinc superdioxide dismutase 1
- mostly single aa substitutions
what is SOD1
- antioxidant enzyme that breaks down superoxide radicals
where is SOD1 found
cytosol, mitochondira, nucleus, ER
what is another name for single aa substitutions
missense mutations
new treatment for ALS relating to SOD1 mutations
new antisense oligomer (ASO) treatment
- Tofersen
- prevents it being expressed
C9orf72 mutations and ALS
- most common cause of ALS
- also causes FTD
- large hexanucleotide repeat expansion (excess sequences in gene)
how does the C90rf72 mutation cause genes to die
- in intron 1 or promoter region (non-coding)
- expansion gets transcribed
- expansion translated to produce 5 repetitive dipeptides (DPRs)
- not meant to exist in human brain and become toxic
TARDBP what is it
- encodes for TDP-43 (transactive response DNA-binding protein 43) (and RNA-binding protein)
what is the role of TARDBP
- DNA repair and RNA processing: regulates transcription, translation, splicing
- primarily nuclear
TARDBP in ALS
- > 40 mutations linked to ALS
- rare ~1-3% of all ALS
- also linked to FTD
neurodegeneration in ALS motor cortex
- stains show far less/ little cell bodies of motor neurons
protein aggregation in neurodegeneration
- insoluble intraneuronal protein aggregates/inclusions in all neurodegenerative disease
- different proteins in different diseases/ sub-types of disease
- proteins are ubiquitinated and (hyper-)phosphorylated
most common aggregates in ALS
- SOD1
- TARDBP
(one or the other)
most common ALS mutations
- C9orf72
- SOD1
most common insoluble protein inclusions found in motor neurons
- TDP-43
note
- toxicity of misfolded/ aggregating proteins not fully understood